Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody.
about
Immune complexes as therapy for autoimmunityHuman Fc gamma RIII: cloning, expression, and identification of the chromosomal locus of two Fc receptors for IgGImmune thrombocytopeniaTargeting the Fc receptor in autoimmune diseaseImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesImmunoglobulin G-mediated inflammatory responses develop normally in complement-deficient miceCharacterization of polymorphic forms of Fc receptor III on human neutrophils.Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?Conjugation of methotrexate to immunoglobulins kills macrophages by Fc receptor mediated uptake?Fc receptors in immune thrombocytopenias: a target for immunomodulation?The role of Fcgamma receptors in murine autoimmune thrombocytopenia.The pathophysiology, diagnosis and management of autoimmune thrombocytopenia.Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.ITP: a historical perspective.The isotype of autoantibodies influences the phagocytosis of antibody-coated platelets in autoimmune thrombocytopenic purpura.Low expression of FCGRIIB in macrophages of immune thrombocytopenia-affected individuals.Novel treatments for immune thrombocytopenia.Association of primary immune thrombocytopenia and common allergic diseases among children.Long-term response in a patient with ITP following low dose anti-D immunoglobulin therapy.Medical and surgical management of spontaneous hyphaema secondary to immune thrombocytopeniaAtopic dermatitis and association of risk for primary immune thrombocytopenia and autoimmune diseases among children: A nationwide population-based cohort study.Mouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptors.Emerging drugs for immune thrombocytopenia (ITP).Neutropenia following intravenous immunoglobulinHarmful and beneficial antibodies in immune thrombocytopenic purpura.Idiopathic thrombocytopenic purpura (ITP): immunomodulation by intravenous immunoglobulin (IVIg).Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.Analysis of competition binding between soluble and membrane-bound ligands for cell surface receptors.An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosusSoluble Fc gamma receptor III in human plasma originates from release by neutrophilsClearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines.Function and heterogeneity of human Fc receptors for immunoglobulin G.Immunomodulatory action of intravenous immunoglobulin.The immune destruction of red cells.Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.Hydrodynamic delivery of plasmid DNA encoding human FcγR-Ig dimers blocks immune-complex mediated inflammation in miceIVIG in APS pregnancy.In vivo clearance by the mononuclear phagocyte system in humans: an overview of methods and their interpretation.CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes.Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes.
P2860
Q24558642-95C673A8-E938-4CA9-AE80-B654B036D80EQ24625901-3450FF72-EAD2-4945-A4FC-A45AA133B1E2Q26830918-8E5378A4-3B4F-4AB4-A1C0-982692B6044DQ27002843-75EC3777-FE3B-4D8C-A65C-C003916017B2Q28069362-2FF6BBCA-E856-4D7A-B845-27797477A960Q28593561-A7B6932E-BDCF-42FB-9E69-AD3DEFC8B0E8Q30366956-C146FCCE-70F9-49DC-B49A-5F6721E0FAB9Q33336653-F1BEB60C-78E6-4621-9E41-96F08A758A3DQ33379596-C99CE77A-951A-4C5A-A0EA-F710FAB2F2BBQ33380494-E12ADD97-B95B-429A-BD63-715422368F41Q33388368-E4AE048F-8F49-47E7-A5A0-B5047D51D4BFQ33392632-09E7BAEB-DDFC-42C4-8D04-3E3999A864EAQ33394438-1871486B-BA3D-4B3E-9042-73084CD8B85DQ33394791-3EAE6142-C7EF-4082-99FA-A52656695E58Q33396360-780B8A99-DA80-41B6-90D8-48650BBFF81BQ33403755-3D52A2FC-979F-4A00-BC5E-836BA564FF9CQ33414132-DC7ED2A3-5A33-4591-90B4-7F9AA8C3012BQ33419742-9D9AC805-801B-40C8-9DE3-36B002B9D0B9Q33420004-D505D6DE-F15F-4C50-BE24-1D832DED94ABQ33423464-9A02221E-1166-4DC1-8811-81F35E4B59A0Q33434063-8EA6333F-41A3-49BF-8DC8-A3E6C317BDB0Q33437935-E956FA12-0132-4C6E-9F55-4909CBB9F941Q33439789-E1D34E4D-32EF-4801-A13C-0A04FA26C23CQ33447466-3D00B929-437F-4B78-8A19-0A8E19B618F5Q33491681-E6756A68-CC8B-426D-97BD-F870489C3921Q33496171-61D5C941-B755-4E18-A0A1-715C4ACB239DQ33596381-15E0F57E-9A1E-4820-8B04-02D7C1799733Q34172091-ACCE0A7B-F12A-4799-897C-CB7C0E548FDCQ34256992-ED7DBE4F-2743-4F90-B23B-C608FCE676BFQ34257727-FAB2DD1F-58B0-43CB-9F1F-38A6B3429DEEQ34323394-0F4E5ECF-12BF-470C-9BC9-718BD2938539Q34565354-32B0D32D-30A2-46CA-87CB-1E44E4C249F1Q35013334-EE6573A6-07F7-4596-85DB-6DE8A58184E5Q35224314-5BB8CEEF-4F9D-4D92-8C63-859AC27875C5Q35810373-65C0A46D-C7D1-4739-8A6C-F36E734AAF73Q35812595-A1CCA189-F9CF-48C8-93C4-FDFC98617AAAQ35918396-D50D2CAE-0E51-415A-BF32-1D3EF52C24C2Q36311772-2238341F-7C0F-4A4B-88DD-8F677299E3ECQ36354512-173818C9-97D7-4E84-B5E6-83E2C8CB887DQ36356813-84DF0D36-8539-453F-9128-12F5BA6F37CE
P2860
Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody.
description
1986 nî lūn-bûn
@nan
1986 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Treatment of refractory immune ...... ti-Fc gamma-receptor antibody.
@ast
Treatment of refractory immune ...... ti-Fc gamma-receptor antibody.
@en
type
label
Treatment of refractory immune ...... ti-Fc gamma-receptor antibody.
@ast
Treatment of refractory immune ...... ti-Fc gamma-receptor antibody.
@en
prefLabel
Treatment of refractory immune ...... ti-Fc gamma-receptor antibody.
@ast
Treatment of refractory immune ...... ti-Fc gamma-receptor antibody.
@en
P2093
P1476
Treatment of refractory immune ...... ti-Fc gamma-receptor antibody.
@en
P2093
Clarkson SB
Kimberly RP
Nachman RL
Unkeless JC
Valinsky JE
P304
P356
10.1056/NEJM198605083141907
P407
P577
1986-05-01T00:00:00Z